Arvinas (ARVN) Revenue (2017 - 2026)
Arvinas' (ARVN) quarterly Revenue came in at $15.6 million in Q1 2026, down 91.74% year-on-year from $188.8 million in Q1 2025, and up 64.21% quarter-over-quarter from $9.5 million in Q4 2025.
Arvinas (ARVN) Revenue (2017 - 2026) Analysis & Trends
Arvinas' Revenue history runs 10 years deep, the most recent figure standing at $15.6 million for Q1 2026.
- On a quarterly basis, Revenue fell 91.74% year-over-year to $15.6 million in Q1 2026; TTM through Mar 2026 was $89.4 million, a 79.06% decrease from a year earlier, with the FY2025 full-year figure at $262.6 million, changed 0.3% from the prior year.
- Revenue climbed to $15.6 million in Q1 2026 per ARVN's latest filing, from $9.5 million in the prior quarter.
- Across five years, Revenue topped out at $188.8 million in Q1 2025 and bottomed at -$43.1 million in Q4 2023.
- The 5-year median for Revenue is $33.8 million (2022), against an average of $44.2 million.
- Across the five-year window, Revenue slumped 214.02% in 2023 and surged 646.25% in 2025, its largest moves.
- Year by year, Revenue stood at $37.8 million in 2022, then slumped by 214.02% to -$43.1 million in 2023, then surged by 237.35% to $59.2 million in 2024, then sank by 83.95% to $9.5 million in 2025, then soared by 64.21% to $15.6 million in 2026.
- Per Business Quant, the three latest ARVN Revenue figures stand at $15.6 million (Q1 2026), $9.5 million (Q4 2025), and $41.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - | 15.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.60 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 41.90 Mn |
| Jun 30, 2025 | 22.40 Mn |
| Mar 31, 2025 | 188.80 Mn |
| Dec 31, 2024 | 59.20 Mn |
| Sep 30, 2024 | 102.40 Mn |
| Jun 30, 2024 | 76.50 Mn |
| Mar 31, 2024 | 25.30 Mn |
| Dec 31, 2023 | -43.10 Mn |
| Sep 30, 2023 | 34.60 Mn |
| Jun 30, 2023 | 54.50 Mn |
| Mar 31, 2023 | 32.50 Mn |
| Dec 31, 2022 | 37.80 Mn |
| Sep 30, 2022 | 33.20 Mn |
| Jun 30, 2022 | 33.80 Mn |
| Mar 31, 2022 | 26.50 Mn |
| Dec 31, 2021 | 33.20 Mn |
| Sep 30, 2021 | 9.30 Mn |
| Jun 30, 2021 | 5.50 Mn |